BrainStorm Gets FDA Fast-track Status For ALS Stem Cell Therapy – Business Insider
|
BrainStorm Gets FDA Fast-track Status For ALS Stem Cell Therapy
Business Insider TEL AVIV (Reuters) – Israel's BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration has designated its adult stem cell treatment as a "fast-track" product for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm's … |
